StonvexLoading…
StonvexStonvexStonvexCore line items from EMYB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $18.50M | $71.46M | $52.92M | $34.66M |
Operating Income | $4.58M | $16.60M | $12.24M | $7.64M |
Net Income | $3.74M | $13.70M | $10.12M | $3.44M |
EPS (Diluted) | $0.50 | $1.79 | $1.32 | $0.83 |
Total Assets | $1.84B | $1.80B | $1.78B | $1.76B |
Total Liabilities | $1.72B | $1.67B | $1.66B | $1.65B |
Cash & Equivalents | $141.83M | $112.86M | $108.00M | $91.82M |
Free Cash Flow OCF − CapEx | $4.66M | $12.20M | $8.45M | $4.58M |
Shares Outstanding | 7.41M | 7.55M | 7.65M | 7.65M |